These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16650363)

  • 21. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
    Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W; Phongtuntakul B
    J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease.
    Yildiz A; Cakar MA; Baskurt M; Okcun B; Guzelsoy D; Coskun U
    Cardiovasc Ultrasound; 2007 Dec; 5():51. PubMed ID: 18163915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
    Simons LA; Sullivan D; Simons J; Celermajer DS
    Atherosclerosis; 1998 Mar; 137(1):197-203. PubMed ID: 9568752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
    Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
    J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
    Charbonneau F; Anderson TJ; Title L; Jobin J; Poirier P; Huyhn T; Chan S; Walling A; Hutchison S; Tran T; Lonn E; Buithieu J; Genest J
    Atherosclerosis; 2008 Mar; 197(1):420-7. PubMed ID: 17673219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
    Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP
    Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level.
    Tantikosoom W; Thinkhamrop B; Kiatchusakul S; Jarernsiripornkul N; Srinakarin J; Ojongpian S
    J Med Assoc Thai; 2005 Mar; 88(3):399-406. PubMed ID: 15962651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin improves endothelial function in renal-transplant recipients.
    Asberg A; Hartmann A; Fjeldså E; Holdaas H
    Nephrol Dial Transplant; 2001 Sep; 16(9):1920-4. PubMed ID: 11522880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.
    Economides PA; Caselli A; Tiani E; Khaodhiar L; Horton ES; Veves A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):740-7. PubMed ID: 14764790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of high-density lipoprotein cholesterol with improvement of endothelial dysfunction recovery in renovascular disease.
    Yasmeen G; Dawani ML; Mahboob T
    Iran J Kidney Dis; 2015 Jan; 9(1):39-45. PubMed ID: 25599735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
    Vlachopoulos C; Aznaouridis K; Dagre A; Vasiliadou C; Masoura C; Stefanadi E; Skoumas J; Pitsavos C; Stefanadis C
    Eur Heart J; 2007 Sep; 28(17):2102-9. PubMed ID: 17597050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
    Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
    Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.